Navigation Links
BBVA Foundation international study on attitudes to stem cell research
Date:5/14/2008

ments (Human Fertilization and Embryology Authority) approved the creation of hybrid embryos for the purpose of obtaining stem cells for biomedical research. The technique in question involves the implanting of the nucleus of an adult human cell into the egg of an animal from which the nucleus has been previously extracted.

The BBVA Foundation survey also questioned citizens about their attitudes to such advances. The creation of hybrid embryos causes divided reactions both between and within countries. The baseline scenario meets with attitudes of rejection (below 5 on an acceptance scale from 0 to 10) in most of the countries studied. Only in the Czech Republic, Spain, Italy, Israel and Denmark does the mean score approach the midpoint on the scale. The citizens of Poland, France, Austria and Germany are the most critical of this application.

Predominant in most countries is the fear that the technique could get out of control and lend itself to dangerous uses. This feeling appears to run deepest in Poland, France, Austria and Israel. A rather different reaction emerges in Denmark, the Netherlands and Sweden, where rejection of the creation of hybrids appears to have less to do with fear, and possibly more to do with perceptions that it is interfering with nature.


'/>"/>

Contact: Communication Department
comunicacion@fbbva.es
Fundacin BBVA
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Landon Foundation-AACR INNOVATOR Awards
2. National Lung Cancer Partnership and LUNGevity Foundation
3. UTSA receives $822,000 from Kleberg Foundation to enhance scientific research
4. Cummings School receives Rockefeller Foundation grant
5. Helios Education Foundation invests $6.5 million
6. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
7. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
8. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
9. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
10. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
11. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a ... announced that its DigitalPersona ® Pro Enterprise ... have been deployed throughout First Bank branch locations ... South Carolina and Virginia. First Bank, ... Southern Pines, North Carolina , selected ...
(Date:12/3/2014)... As part of our commitment to offering ... to announce the release of a new reader that ... workforce data that they need. The Atlas ... existing readers. Many such devices have serious shortcomings when ... Older models force users to navigate numerous complicated steps ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2
... average temperatures of the atmosphere are rising; the average ... react sensititvely to these changes. The transitional zones between ... slopes store a huge amount of methane hydrates in ... at low temperatures and under high pressure. When the ...
... levels of hormones that are associated with stress are a ... but recent research on young songbirds found that some elevated ... life and death. The new research concluded that elevated ... response to stress, were related to the movement, feeding, and ...
... at The University of Nottingham have discovered a new ... These new materials could lead to a significant reduction ... device associated infections can lead to systemic infections or ... many commonly used devices including urinary and venous catheters ...
Cached Biology News:Are methane hydrates dissolving? 2For young birds, getting stressed out can be a good thing 2New bacteria-resistant materials discovered 2New bacteria-resistant materials discovered 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... BioPharma Corp. (TSX, FSE: "HBP") announced that its registration ... the U.S. Securities and Exchange Commission ("SEC").Accordingly, Helix,s common ... Section 12(g) of the Securities Exchange Act of 1934, ... States allows its shares to be solicited and traded ...
... Corporation (NYSE: BSX ) today announced that ... to stable from negative. In addition, Moody,s upgraded ... Ba2 and its liquidity rating to SGL-2 from SGL-3, ... Moody,s said the revised rating outlook reflects: (1) ...
... March 12 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the ... and supplier,of branded generic pharmaceuticals and manufacturer of the ... financial,results for the quarter and fiscal year ended December ... -- Total revenue increased to RMB 466.9 ...
Cached Biology Technology:Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC 2Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC 3Moody's Raises Boston Scientific's Rating Outlook to Stable 2Moody's Raises Boston Scientific's Rating Outlook to Stable 3Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 2Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 3Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 4Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 5Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 6Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 7Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 8Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 9Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 10Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 11Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 12Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results 13
BAI-1 (T-20)...
MOUSE ANTI HUMAN CYTOKERATIN 1-8...
GOAT ANTI HUMAN PSA (ISOFORM 1)...
... peptide derived from the N-terminal region of ... Specificity: Specific for the N-terminus of the ... Dog Rat Mouse (positive controls: MDCK-II A431 ... heart blood vessel and brain mossy fiber ...
Biology Products: